Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 6 results for "mao xin gong"

Sanam-Jeevan duo exits

Sanam Singh and Jeevan Nedunchezhiyan lost 6-3, 7-6(11) to Gong Mao-Xin of China and Chu-Huan Yi of Chinese Taipei in the doubles pre-quarterfinals of the $50,000 mens Challenger in Bangkok on Wednesday. The results: $250,000 WTA, Strasbourg, France: Doubles ... The Hindu, 1 month ago

Survey Exposes Propaganda Agency's Campaign Against Chinese Leader

Advanced blackening might sound like a marketing slogan gone awry—the reverse of a toothpaste commercial—but a Communist Party mouthpiece seems intent on having the Chinese citizenry better acquainted with other connotations of the term. Namely, ...
 Epoch Times4 weeks ago

Challenger tennis: Ramkumar makes last eight

Ramkumar Ramanathan made the quarterfinals of the $50,000 men's Challenger tennis tournament with a 7-5, 6-3 victory over Steven Diez of Canada in Samarkhand, Uzbekistan, on Thursday. The results: $100,000 Challenger men, Seoul, Korea: Doubles ...
 The Hindu1 month ago
Kazinform

Kazakh-Ukrainian tennis duo into Nanjing Challenger semis

ASTANA. KAZINFORM - Kazakhstan's tennis player Aleksandr Nedovyesov and Ukrainian Denys Molchanov reached the semifinals of the men's doubles event at the TAC Cup China International Nanjing Challenger 2016. In the quarterfinals Nedovyesov and ...
 Kazinform2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less